CLINICAL_TRIALS
trial_result
· 2025-03-07
Clinical Trial Update: Low Dose Tamoxifen for Mammographic Density Reduction [Phase 2]
Summary
Phase 2 trial evaluating low-dose tamoxifen to reduce mammographic density as a surrogate for breast cancer risk reduction; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Per Hall | Conditions: Risk Reduction, Mammographic Density Reduction | Phase 2 | Status: COMPLETED | Results posted: 2025-03-07